Synaptosomal response to oxidative stress: Effect of vinpocetine

References

• Siesjo B.K., Agarth C.D., Begtsson F. Free radicals and brain damage. Cerebrovascular Brain Metabolism Reviews 1989; 1: 165–211
   PubMedGoogle Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. Journal of Neurochemistry 1992; 59: 1609–1623
   PubMed Web of Science ®Google Scholar
• Coyle J.T., Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262: 689–695
   PubMed Web of Science ®Google Scholar
• Olanow C.W. A radical hypotheses for neurodegeneration. Trends in Neurosciences 1993; 16: 439–444
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochemical Journal 1994; 219: 1–14
   Google Scholar
• Phillis J.W. A “radical” view of cerebral ischemic injury. Progress in Neurobiology 1994; 42: 441–498
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J.M.C. Oxygen radicals and the nervous system. Trends in Neurosciences 1985; 8: 22–26
   Web of Science ®Google Scholar
• Evans P.H. Free radicals in brain metabolism and pathology. British Medical Bulletin 1993; 49: 577–587
   PubMed Web of Science ®Google Scholar
• Schultz J.B., Henshaw D.R., Siwek D., Jenkins B.G., Ferrante R.J., Cipolloni P.B., Kowall N.W., Rosen B.R., Beal M.F. Involvement of free radicals in excitotoxicity in vivo. Journal of Neurochemistry 1995; 64: 2239–2247
   PubMedGoogle Scholar
• Sims N.R., Zaidan E. Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. International Journal of Biochemistry and Cell Biology 1995; 27: 531–550
   PubMed Web of Science ®Google Scholar
• Hall E.D., Braughler J.M. Central nervous system trauma and stroke II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radicals in Biology and Medicine 1989; 6: 303–313
   PubMed Web of Science ®Google Scholar
• Pellegrini-Giampietro D., Cherici G., Alesiani M., Carla V., Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. Journal of Neuroscience 1990; 10: 1035–1041
   PubMed Web of Science ®Google Scholar
• Globus O., Alonso W.D., Dietrich W.D., Busto R., Ginsberg M.D. Glutamate release and free radical production following brain injury: effects of post traumatic hypothermia. Journal of Neurochemistry 1995; 65: 1704–1711
   PubMed Web of Science ®Google Scholar
• Lancelot E., Callebert J., Revaud M.L., Boulu R.G., Plotkine M. Detection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damage. Neuroscience Letters 1995; 197: 85–88
   PubMedGoogle Scholar
• McIntosh T.K. Novel pharmacological therapies in the treatment of experimental traumatic brain injury: a review. Journal of Neurotrauma 1993; 10: 215–261
   PubMed Web of Science ®Google Scholar
• Nakao N., Grasbon-Frodl E.M., Widner H., Brundin P. Antioxidant treatment protects neurons against striatal neurons excitotoxic insults. Neuroscience 1996; 73: 185–200
   PubMedGoogle Scholar
• Hensley K., Carney J.M., Stewart C.A., Tabatabaie T., Pye Q., Floyd R.A. Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies. Neuroprotective Agents and Cerebral Ischemia, A.R. Green, A.J. Cross. Academic Press, New York 1997; 299–317, In
   Google Scholar
• King G.A. Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice. Archives internationals de Pharmacodynamie et de Thérapie 1987; 286: 299–307
   PubMedGoogle Scholar
• Sauer D., Rischke R., Beck T., Roßberg C., Mennel H.D., Bielenberg G.W., Krieglstein J. Vinpocetine prevents ischemic cell damage in rat hippocampus. Life Sciences 1988; 43: 1733–1739
   PubMed Web of Science ®Google Scholar
• Miyamoto M., Murphy T.M., Schnaar R.L., Coyle J.T. Antioxidants protect glutamate-induced cytotoxicity in a neuronal cell line. Journal of Pharmacology and Experimental Therapeutics 1989; 250: 1132–1140
   PubMed Web of Science ®Google Scholar
• Erdö S.L., Ning-sheng C., Wolff J.R., Kiss Béla. Vinpocetine protects against excitotoxic cell death in primary cultures of rat cerebral cortex. European Journal of Pharmacology 1990; 187: 551–553
   PubMed Web of Science ®Google Scholar
• Lakics V., Sebestyén M.G., Erdö S.L. Vinpocetine is a highly potent neuroprotectant against veratridine-induced cell death in primary cultures of rat cerebral cortex. Neuroscience Letters 1995; 185: 127–130
   PubMed Web of Science ®Google Scholar
• Tretter L., Adam-Vizi V. The neuroprotective drug vinpocetine prevents veratridine-induced [Na+]i and [Ca2+]i rise in synaptosomes. NeuroReport 1998; 9: 1849–1853
   PubMed Web of Science ®Google Scholar
• Schmidt J. Comparative studies on the anti-convulsant effectiveness of nootropic drugs in kindled rats. Biomedica Biochimica Acta 1990; 49: 413–419
   PubMedGoogle Scholar
• Palmeira C.M., Santos M.S., Oliveira C.R. Membrane lipid peroxidation induces changes in the γ-[3H]aminobutyric acid transport and Ca2+ uptake in synaptosomes. Brain Research 1993; 609: 117–123
   PubMedGoogle Scholar
• Cardoso S.M., Pereira C., Oliveira C.R. The protective effect of Vitamin E, Idebenone and reduced glutathione on free radical mediated injury in rat brain synaptosomes. Biochemical and Biophysical Research Communications 1998; 246: 703–710
   PubMedGoogle Scholar
• Hajós F. An improved method for the preparation of synaptosomal fractions in high purity. Brain Research 1975; 93: 485–489
   PubMed Web of Science ®Google Scholar
• Ernster L., Nordenbrand K. Microsomal lipid peroxidation. Methods in Enzymology 1967; 10: 574–580
   Google Scholar
• Dinis T.C., Madeira V.M.C., Almeida L. Action of phenolic derivatives (Acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Archives of Biochemistry and Biophysics 1994; 315: 161–169
   PubMed Web of Science ®Google Scholar
• Bass D.A., Parce J.W., Dechatelet L.R., Szejda P., Seeds M.C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. Journal of Immunology 1983; 130: 1910–1917
   PubMed Web of Science ®Google Scholar
• Royall J.A., Ischiropoulos H. Evaluation of 2′,7′-dichlorofluorescein and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Archives of Biochemistry and Biophysics 1993; 302: 348–355
   PubMed Web of Science ®Google Scholar
• Carter P. Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Analytical Biochemistry 1971; 40: 450–458
   PubMed Web of Science ®Google Scholar
• Rubinstein J.D., Lesnefsky E.J., Byler R.M., Fennessey P.V., Horwitz L.D. Trolox C, a lipid-soluble membrane protective agent, attenuates myocardial injury from ischemia and reperfusion. Free Radicals in Biology and Medicine 1992; 13: 627–634
   PubMed Web of Science ®Google Scholar
• Gutteridge J.M.C., Halliwell B. The measurements and mechanism of lipid peroxidation in biological systems. Trends in Biochemical Sciences 1990; 15: 129–135
   PubMed Web of Science ®Google Scholar
• Sassa H., Takaishi Y., Terada H. The triterpeno celastrol as a very potent inhibitor of lipid peroxidation in mitochondria. Biochemical and Biophysical Research Communications 1990; 172: 890–897
   PubMed Web of Science ®Google Scholar
• Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radicals in Biology and Medicine 1990; 9: 515–540
   PubMed Web of Science ®Google Scholar
• Callaway J.K., Beart P.M., Jarrott B. A reliable procedure for comparison of antioxidants in rat brain homogenates. Journal of Pharmacology and Toxicological Methods 1998; 39: 155–162
   PubMed Web of Science ®Google Scholar
• LeBel C.P., Ali S.F., McKee M., Bondy S.C. Organometal-induced increases in oxygen reactive species: the potential of 2′-7′-dichlorofluorescein diacetate as an index of neurotoxic damage. Toxicology and Applied Pharmacology 1990; 104: 17–24
   PubMed Web of Science ®Google Scholar
• Kooy N.W., Royall J.A., Ischiropoulos H. Oxidation of 2′,7′-Dichlorofluorescein by peroxynitrite. Free Radical Research 1997; 27: 245–257
   PubMed Web of Science ®Google Scholar
• Possel H., Noack H., Augustin W., Keilhoff G., Wolf G. 2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Letters 1987; 416: 175–178
   Google Scholar
• Henderson L.M., Chappell J.B. Dihydrorhodamine 123: a fluorescent probe for superoxide generation. European Journal of Biochemistry 1993; 217: 973–980
   PubMedGoogle Scholar
• Kooy N.W., Royall J.A., Ischiropoulos H., Beckman J.S. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radicals in Biology and Medicine 1994; 16: 149–156
   PubMed Web of Science ®Google Scholar
• Witting L.A. Vitamin E and lipid antioxidants in free-radical initiated reaction. Free Radical in Biology, W.A. Pryor. Academic Press, New York 1980; 295–319, In
   Google Scholar
• Agostinho P., Duarte C.B., Oliveira C.R. Impairment of excitatory amino acid transporter activity by oxidative stress conditions in retinal cells: effect of antioxidants. FASEB Journal 1997; 11: 154–163
   PubMedGoogle Scholar
• Rego A.C., Santos M.S., Proença M.T., Oliveira C.R. Influence of vitamin E on retinal cell survival. Toxicology 1998; 128: 113–124
   PubMed Web of Science ®Google Scholar
• Cardoso S.M., Pereira C., Oliveira C.R. Mitochondrial function is differentially affected upon oxidative stress. Free Radicals in Biology and Medicine 1999; 26: 3–13
   PubMed Web of Science ®Google Scholar
• Agostinho P., Duarte C.B., Oliveira C.R. Intracellular free Na+ concentration increases in cultured retinal cells under oxidative stress conditions. Neuroscience Research 1996; 25: 343–351
   PubMedGoogle Scholar
• Romano C., Price M.T., Olney J.W. Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina. Journal of Neurochemistry 1995; 65: 59–67
   PubMedGoogle Scholar
• Molnár P., Erdö S.L. Vinpocetine is as potent as phenytoin to block voltage-gated Na+ channels in rat cortical neurons. European Journal of Pharmacology 1995; 273: 303–306
   PubMed Web of Science ®Google Scholar
• Kaneko K., Sugimura M., Inoue T., Satoh M. Effects of several drugs on NMDA channel function: evaluation using Xenopus oocytes and [3H] MK-801. European Journal of Pharmacology 1991; 209: 119–128
   PubMedGoogle Scholar
• Kiss B., Cai N.S., Erde S.L. Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies. European Journal of Pharmacology 1991; 209: 109–112
   PubMed Web of Science ®Google Scholar
• Suno M., Nagaoka A. Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of inhibition. Biochemical and Biophysical Research Communications 1984; 125: 1046–1052
   PubMed Web of Science ®Google Scholar
• Krieglstein J., Rischke R. Vinpocetine increases the neuroprotective effect of adenosine. European Journal of Pharmacology 1991; 205: 7–10
   PubMed Web of Science ®Google Scholar
• Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Neuroprotective role of adenosine in ischemia. Trends in Pharmacological Sciences 1992; 13: 439–445
   PubMed Web of Science ®Google Scholar
• Pudleiner P., Vereczkey L. Study on the absorption of vinpocetine and apovincaminic acid. European Journal of Drug Metabolism and Pharmacokinetics 1993; 18: 317–325
   PubMed Web of Science ®Google Scholar
• Vereczkey L., Czira G., Tamás J., Szentirmai Z.S., Botár Z., Szporny L. Pharmacokinetics of vinpocetine in humans. Arzneimittel Forschung 1979; 29: 957–960
   PubMed Web of Science ®Google Scholar